High demand for point-of-care diagnostics and
growing awareness about the womens health related diagnostics drives the market
growth. Focus of manufacturers on development of novel tests; such as hormone
receptor tests and HPV test; to treat womens disorders would have a significant
impact on the market growth throughout the forecast period.
Women's Health Diagnostics Market was
valued at $13,133 million in 2016, and is projected to reach $21,501 million in
2023 at a CAGR of 7.0% from 2017 to 2023.
Gynecology is the main branch of medical
science concerned with women's health problems. This includes the
health-related disorders, their screening and testing procedures. Women are
highly prone to various cancers such as breast, cervical, and ovarian cancer.
Other health issues include infertility, polycystic ovarian syndrome,
menopause, depression, osteoporosis, and obesity.
Download PDF Report
Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/4521
Factors such as rise in prevalence of various
chronic lifestyle disorders in women, rise in female geriatric population who
are more prone to several disorders, increase in adoption of point of care
diagnosis, high demand for imaging and diagnosing centers, and support from
government in promoting awareness about women related disorders. However,
factors such as expensive imaging procedures and lack of skilled professionals
restrains the market growth. Conversely, huge untapped market potential in the
emerging countries, such as South Africa and India, and development of novel
and advanced imaging procedures such as miniature devices are expected to
provide lucrative opportunities to the market players.
The diagnostic tests segment occupied the
largest share in 2016, owing to the high usage, applicability, and availability
of tests for detecting various disorders in women. Furthermore, the accessories
and consumables segment is expected to grow at the highest CAGR of 7.8% from
2017 to 2023, and is anticipated to continue its dominance during the forecast
period. The utilization rate of various women's health related diagnostics
procedures for hospitals and clinics is high, however diagnostic and imaging
centers segment is expected to grow at a CAGR of 7.8% during the forecast
period. This is attributed to increase in incidence of various types of
health-related disorders.
Key findings of the Women's Health
Diagnostics Market:
- Diagnostic tests segment accounted for
around 55.1% share of the global women's health diagnostics market in 2016
- Diagnostic devices segment is expected to
grow at a CAGR of 6.5% from 2017 to 2023.
- Hospitals and clinics segment accounted for
around 49.8% share of the global women's health diagnostics market in 2016
- North America accounted for around 33.7%
share of the global women's health diagnostics market in 2016
- Asia-Pacific is expected to grow at the
highest CAGR of 8.1% from 2017 to 2023
North America was the leading revenue
contributor to the global women's health diagnostics market, accounting for
nearly one-third of the global market. This is attributed to the presence of
numerous screening tests for cancer detection and other diseases. Moreover,
presence of key players and advanced diagnostics procedures such as 3D
mammography. However, Asia-Pacific is expected to grow at the highest CAGR of
8.1% during the study period, due to increase in affordability, surge in
healthcare expenditure, and rise in awareness towards various women related
disorders.
No comments:
Post a Comment